Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun;14(3):347-61.
doi: 10.1016/j.cbpa.2010.02.018. Epub 2010 Mar 18.

Privileged scaffolds for library design and drug discovery

Affiliations
Review

Privileged scaffolds for library design and drug discovery

Matthew E Welsch et al. Curr Opin Chem Biol. 2010 Jun.

Abstract

This review explores the concept of using privileged scaffolds to identify biologically active compounds through building chemical libraries. We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A potential privileged scaffold found in natural products?
Scheme 1
Scheme 1
Synthesis of 1,4-benzodiazepine library Reagents and conditions: (a) 20% piperidine in DMF; (b) N-Fmoc-amino acid fluoride in CH2Cl2; (c) 5% acetic acid in DMF; (d) lithiated 5-phenylmethyl-2-oxazolidinone in DMA/THF, 1:10 (v/v); alkylating agent in DMF; (e) TFA/H2O/Me2S, 95:5:10 (v/v).
Scheme 2
Scheme 2
Solid phase synthesis of 2,6,9-substituted purine library Reagents and conditions: (a) p-methoxybenzylamine, NaBH(OAc)3, AcOH (2%), DMF, 25 °C; (b) SEM-Cl (1.2 eq), DIEA, DMF, 0→25 °C; (c) DIEA, n-BuOH-DMSO (1:1), 7; (d) TBAF (0.25 M), THF, 60 °C; (e) i-PrOH (0.5 M), DIAD (0.5 M), Ph3P (1.0 M), THF/CH2Cl2 (1/1); (f) 3-amino-1-propanol, DIEA, N-methylpyrrolidinone, 110 °C; (g) TFA-H2O (95:5), 25 °C.
Scheme 3
Scheme 3
Two alternative solution phase routes for purine library synthesis Reagents and conditions: (a) R1OH (2 equiv), DEAD (1.1 equiv), Ph3P (2 equiv), THF, -10→25 °C; (b) (CF3)2O, CH2Cl2, 0→25 °C; (c) R2OH (2 equiv), DEAD (1 equiv), Ph3P (2 equiv), THF, 0→25 °C; K2CO3, MeOH; (d) R3R4NH (4 equiv), DIEA, n-BuOH, 110 °C; AcOH/H2O/THF (3/1/1); (e) R1OH (1.2 equiv), DEAD (1.3 equiv), Ph3P (1.3 equiv), THF, -10→25 °C; (f) R2R3NH (1 equiv), DIEA, n-BuOH, 140 °C; (g) R4NH2 (1.5 equiv), DIEA, n-BuOH, 150–170 °C.
Scheme 4
Scheme 4
Synthesis of amide and amine-based 2-arylindole libraries. Reagents and conditions: (a) DIC, THF/CH2Cl2 followed by resin and 4-DMAP; (b) archive, mix and split resin; (c) aryl hydrazine, ZnCl2, AcOH; (d) pentafluorobenzyl alcohol, Ph3P, DIAD, THF; (e) R2R3NH; (f) polystyryl isothiocyanate resin; (g) BMS, dioxane, 50 °C; (h) HCl/MeOH, 50 °C then azeotrope.
Scheme 5
Scheme 5
Initial aldehyde scaffold for 3,3-dimethylbenzopyran library synthesis; schemes illustrates key branching point where organometallic addition, reductive amination and Knoevangel condensation can then occur.

References

    1. Stockwell BR. Exploring biology with small organic molecules. Nature. 2004;432:846–54. - PMC - PubMed
    1. Stockwell BR. Chemical genetics: ligand-based drug discovery of gene function. Nat Rev Genet. 2000;1:116–25. - PMC - PubMed
    1. Payne DJ, Gwynn MN, Holmes DJ, Pomplinano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery. 2007;6:29–40. - PubMed
    1. Breinbauer R, Vetter IR, Waldmann H. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed. 2002;41:2878–2890. The authors discuss natural products as a biologically validated starting point for library construction. They analyze rational library design in the context of structural biology and bioinformatics. - PubMed
    1. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem. 1988;31:2235–2246. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources